Dr. Eric Chiang, MD
What this data tells you about Dr. Chiang
Dr. Eric Chiang is a rheumatology in Corpus Christi, TX, with 15 years in practice. Based on federal Medicare data, Dr. Chiang performed 115,739 Medicare services across 1,375 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chiang received a total of $24,346 from 42 pharmaceutical and/or device companies across 1176 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chiang is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 82,000 | $4 | $18 |
| Romosozumab injection (Evenity) for osteoporosis | 13,230 | $8 | $27 |
| Golimumab infusion (Simponi Aria) | 11,763 | $9 | $45 |
| Denosumab injection (Prolia/Xgeva) | 2,940 | $18 | $63 |
| Steroid injection (triamcinolone) | 2,883 | $1 | $4 |
| Office visit, established patient (30-39 min) | 875 | $87 | $184 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 577 | $52 | $233 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 256 | $65 | $190 |
| Drug injection, under skin or into muscle | 173 | $9 | $43 |
| New patient office visit (45-59 min) | 137 | $111 | $280 |
| Administration of chemotherapy into vein, 1 hour or less | 114 | $92 | $420 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 104 | $4 | $18 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 103 | $20 | $92 |
| Infusion, normal saline solution, 250 cc | 84 | $0 | $21 |
| Infusion into a vein for hydration, each additional hour | 83 | $9 | $50 |
| Injection, ketorolac tromethamine, per 15 mg | 70 | $0 | $2 |
| Ultrasonic guidance for needle placement | 59 | $44 | $101 |
| Injection of additional new drug or substance into vein | 46 | $12 | $48 |
| Injection of carpal tunnel | 42 | $73 | $239 |
| Injection, diphenhydramine hcl, up to 50 mg | 34 | $1 | $5 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 33 | $67 | $262 |
| Injection into tendon or ligament | 30 | $42 | $168 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 30 | $30 | $98 |
| Aspiration and/or injection of fluid from small joint using ultrasound guidance | 26 | $62 | $240 |
| Joint injection, major joint | 16 | $54 | $190 |
| Office visit, established patient (20-29 min) | 16 | $60 | $124 |
| Injection of trigger points, 1-2 muscles | 15 | $38 | $95 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
8.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Chiang is a mixed practice specialist, with above-average Medicare volume (top 12% in TX), and high industry engagement (low-engagement, top 16%), with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Chiang experienced with certolizumab injection (cimzia)?
Does Dr. Chiang receive payments from pharmaceutical companies?
How do Dr. Chiang's costs compare to other rheumatologys in Corpus Christi?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology